The article atai Life Sciences Doses First Patient in New DMT Clinical Trial was originally published on Microdose. While atai Life Sciences (Nasdaq:...
Cybin Inc. (NEO:CYBN | NYSE AMERICAN:CYBN)), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, is pleased to provide...
The Daily Hit is a recap of cannabis business news for October 6, 2022. ON THE SITE Biden To Pardon Marijuana Convictions, Calls For Classification Review...
DMT is the backbone structure of popular psychedelics being tested for medical purposes such as psilocin and LSD The post ‘Endogenous’ DMT plays an...
The article News You Might Have Missed: Oct 3rd, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly...
The article MindMed in Trouble? Serious Problems or Retail Panic? was originally published on Microdose. MindMed in trouble? What a nice attention-grabbing...
Source: Patrick R. Trucchio 09/27/2022 Treatment of alcohol use disorder with psychedelics plus therapy is effective, according to existing...
Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics™, is pleased to announce...
The article Cybin Buys License to Mindset Pharma’s Psychedelic Compounds was originally published on Microdose. Cybin Obtains Exclusive License to a...
Licensing Subset of Mindset’s Family 1 Intellectual Property Underscores Strength of Mindset’s Portfolio and Business StrategyTORONTO, Sept. 27, 2022...